site logo

FDA green lights booster dose of Pfizer vaccine for older, more vulnerable Americans

The decision matches the recommendation made Friday by FDA advisers, who opposed offering a third dose more widely to anyone over 16 years old.

Sarah Silbiger via Getty Images